Under Armour's Turnaround Story Has a Plot Hole: There's No Growth In It
⚠️ Not financial advice. This post is for informational and educational purposes only. Forecasts and commentary are model outputs and opinions, may be inaccurate, and are not a recommendation to buy or sell any security or asset. Do your own research. AI-assisted: this article was drafted with AI and reviewed by a human before publishing.
# Under Armour's Turnaround Story Has a Plot Hole: There's No Growth In It
Kevin Plank wants you to believe Under Armour is cutting its way to greatness. The numbers say he's cutting his way to smaller.
On August 7, Under Armour dropped its first-quarter fiscal 2027 results, and depending on which line you stared at, you walked away either encouraged or unimpressed. Revenue landed at $1.10 billion, down about 3% year over year (4% in constant currency), missing Wall Street's top-line expectations for what feels like the umpteenth quarter running. But adjusted EPS of $0.05 blew past the $0.02 consensus, and adjusted operating income of $52.4 million crushed estimates of $35.6 million. Management responded by keeping its full-year profitability outlook intact while quietly trimming revenue expectations. Read between those lines and the message is clear: we can't sell more stuff, but we're getting really good at spending less to sell it.
That's the whole UAA thesis right now, packed into one earnings print. And it's the reason this stock is such a genuinely fun argument to have.
The bull case, fairly stated
The margin story isn't nothing. Beating operating income estimates by nearly 50% while revenue is shrinking is a real accomplishment, and it's consistent with the deliberate reset Plank has been running since the restructuring program was extended through the end of 2026, with total costs now projected around $305 million. Cutting 25% of SKUs, backing off promotions, and pushing toward premium positioning is the textbook turnaround playbook — trade top-line pain now for better unit economics later. And the valuation backdrop makes the bet interesting: a company doing roughly $5 billion in annual sales trading at a market cap that's been down around $2 billion earlier this year is either a value trap or a coiled spring, and turnaround investors love exactly that kind of ambiguity. Shares even popped 3.55% two sessions before this writing, which tells you there are still buyers willing to bet on the spring.
The bear case, which is doing most of the heavy lifting
Here's the problem: you can't cost-cut your way to a growth story forever, and UAA is running out of quarters to prove this is stabilization rather than managed decline. Revenue has now fallen in back-to-back quarters — down 3% in Q1 FY27, down 0.6% in Q4 FY26 — after a brutal FY25 that saw North America down 15-17%. Net income in the "good" quarter was $1 million. One million dollars, on $1.1 billion in sales. The quarter before that produced a $43.4 million net loss. Net margins sit at -9.94%. Debt-to-equity is at 0.96, which is not where you want to be while your revenue line keeps sliding backward. Barclays isn't buying the turnaround either — they downgraded to Underweight with a $5 target, citing market share losses, tariffs, and a turnaround that's moving slower than advertised. EPS estimates across the Street have cratered from $1.16 to -$0.80 in the span of a month. That's not a rounding error; that's the analyst community losing faith in real time.
And short interest tells the same story from the trading floor: roughly 24% of the float is sold short. That's a crowd that has read the same 10-Q you have and concluded the SKU-cutting, promo-pulling, premium-chasing strategy is more expensive and slower than the market's given it credit for.
Where I land
Technically, the stock is oversold — RSI near 30, sitting between $4.13 support and $5.87 resistance, with both the 20- and 50-day moving averages pointed decisively south. Oversold bounces are real, and short-covering rallies on this much short interest can be violent. But a bounce off oversold conditions is a trade, not a thesis.
The thesis requires revenue to stop falling, and nothing in this report — or the one before it, or the one before that — shows that happening. Plank is proving he can run a leaner shop. He has not yet proven he can run a growing one. Until Under Armour posts a quarter where the top line doesn't miss and the bottom line doesn't need an asterisk, this remains what it's been for a year: a margin story wearing a growth stock's clothes. Watch the revenue line, not the adjusted EPS beat. The revenue line is the one that eventually decides everything else.
More on UAA
Market commentary from the K3vl4r desk — not personalized investment advice. More posts →